News

AFCR Launches the Double Your Impact Campaign in Partnership with Hugill & Ip

FOR IMMEDIATE RELEASE: 1 February 2023 CONTACTS: Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: marco.raccuia@hugillandip.com World Cancer Day – held every 4 February – is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action, UICC partners…...

Read more

Be a Spark of Hope for Cancer Patients – Renew Your Support Today!

As the year comes to a close, I wanted to reach out and ask for your support in our year-end fundraising campaign. Your generosity has the power to ignite a spark of hope for cancer patients and their families who are fighting an incredibly difficult battle. Your contribution will make a real difference…...

Read more

AFCR Annual Reception: A Community Effort to Find Cures for Cancer

On December 15, 2022, the Asian Fund for Cancer Research (AFCR) held its annual reception for community support of cancer research in Hong Kong. The event was a great success, thanks to the support of generous donors, attendees, and inspiring speakers who shared their thoughts on the importance of cancer…...

Read more

AFCR Mourns the Loss of Scientific Advisory Board Member Professor George Tsao

The Asian Fund for Cancer Research Limited (AFCR) is saddened by the loss of George Sai Wah Tsao, Ph.D., who was a professor at the School of Biomedical Sciences and the Director of the Faculty Core Facility of the Faculty of Medicine at the University of Hong Kong. Professor Tsao…...

Read more

94% of the U.S. population has been infected with the new coronavirus

By November 10, 2022, 94% (95% CrI, 79%-99%) of the US population were estimated to have been infected by SARS-CoV-2 at least once. Combined with vaccination, 97% (95%-99%) were estimated to have some prior immunological exposure to SARS-CoV-2. Between December 1, 2021 and November 10, 2022, protection against a new…...

Read more

Impact Investment: Interview with Arbele

  The Asian Fund for Cancer Research aims to accelerate cancer research and technologies through international collaborations.  As part of our mission, AFCR has created the BRACE Award Venture Competition to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into…...

Read more

Promising Cancer Research Programs Need Your Help!

I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue potentially life-saving research projects. Generous friends like you will help determine which investigations will be…...

Read more

AFCR-Funded Innovative Immunotherapy Received Clinical Trial Approval!

Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent great progress!  With your previous support and funding, the drug indicated for the potential treatment…...

Read more

AFCR Congratulates Professor Nancy Ip for Being Appointed as the President of The Hong Kong University of Science and Technology (HKUST)

The Asian Fund for Cancer Research Limited congratulates world-renowned neuroscientist, Nancy Ip, Ph.D., the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST) on her appointment as its President-Elect beginning October 2022. Prof. Ip…...

Read more

Early Detection Tools Saving Time and Saving Lives

A NEW TEST CAN IDENTIFY A RANGE OF CANCERS IN PATIENTS WITH NON-SPECIFIC SYMPTOMS. One of the most troubling things about cancer is the time it can take to reach a diagnosis if the symptoms are not clear-cut. While some cancers are easy to identify and test for, some patients…...

Read more